Literature DB >> 8558735

Vascular surgery in the United States: workforce issues. Report of the Society for Vascular Surgery and the International Society for Cardiovascular Surgery, North American Chapter, Committee on Workforce Issues.

J C Stanley1, R W Barnes, C B Ernst, N R Hertzer, J A Mannick, W S Moore.   

Abstract

The Committee on Workforce Issues of the Society for Vascular Surgery (SVS) and the North American Chapter, International Society for Cardiovascular Surgery (NA-ISCVS) generated data on the numbers and trends of operations performed and workforce requirements to provide surgical care of patients with vascular disease. Data for analysis were obtained from The National Center for Health Statistics-National Hospital Discharge Survey and questionnaires sent to 2732 vascular surgeons. The data showed that SVS/NA-ISCVS and regional vascular society (RVS) surgeons performed 51% of 583,000 vascular procedures undertaken in the United States in 1992. This represents a 24% increase over the 41% reported in 1985 by similarly defined surgeons. Analysis of 1992 index cases documented that SVS/NA-ISCVS and RVS surgeons accounted for 80% of 31,000 aortoiliofemoral bypasses, 68% of 46,000 aortic aneurysmectomies, 64% of 91,000 carotid endarterectomies, and 72% of 98,000 angioaccess procedures. The mean numbers of vascular operations performed in 1992 by SVS/NA-ISCVS and RVS surgeons were 144 and 100, respectively. These procedures represented 64% and 39% of the total surgical caseload of SVS/NA-ISCVS and RVS surgeons, respectively. American Board of Surgery (ABS)-certified vascular surgeons performed a mean of 171 vascular operations in 1992. Other surgeons, including ABS-certified general surgeons, appear to be performing fewer vascular operations. The latter fact and the increasing incidence of vascular disease in an expanding elderly population supports a continued need for vascular surgery specialists. Evolving technology and new health care delivery systems, however, may lessen the need for surgical care of these patients. Continued assessments of workforce activity will allow better definition of changing vascular surgery needs.

Entities:  

Mesh:

Year:  1996        PMID: 8558735     DOI: 10.1016/s0741-5214(05)80050-3

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  11 in total

1.  Rates of lower-extremity amputation and arterial reconstruction in the United States, 1979 to 1996.

Authors:  J Feinglass; J L Brown; A LoSasso; M W Sohn; L M Manheim; S J Shah; W H Pearce
Journal:  Am J Public Health       Date:  1999-08       Impact factor: 9.308

Review 2.  Recent developments in vascular surgery.

Authors:  Jeremy Crane; Nick Cheshire
Journal:  BMJ       Date:  2003-10-18

3.  Cystatin C deficiency promotes inflammation in angiotensin II-induced abdominal aortic aneurisms in atherosclerotic mice.

Authors:  Stephanie Schulte; Jiusong Sun; Peter Libby; Lindsey Macfarlane; Chongxiu Sun; Marco Lopez-Ilasaca; Guo-Ping Shi; Galina K Sukhova
Journal:  Am J Pathol       Date:  2010-05-14       Impact factor: 4.307

4.  Aneurysmal lesions of patients with abdominal aortic aneurysm contain clonally expanded T cells.

Authors:  Song Lu; John V White; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Kyle Evans; Nectaria Ntaoula; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  J Immunol       Date:  2014-04-21       Impact factor: 5.422

5.  Apolipoprotein A-I mimetic peptide reverses impaired arterial healing after injury by reducing oxidative stress.

Authors:  Michael A Rosenbaum; Pinaki Chaudhuri; Benjamin Abelson; Brandy N Cross; Linda M Graham
Journal:  Atherosclerosis       Date:  2015-06-18       Impact factor: 5.162

6.  Treatment of severe chronic venous insufficiency using the subfascial endoscopic perforator vein procedure.

Authors:  H C Baron; M G Wayne; C Santiago; I Lown; M Castellano; M Cioroiu; R Grossi
Journal:  Surg Endosc       Date:  2004-11-11       Impact factor: 4.584

7.  T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm.

Authors:  Uwe Schönbeck; Galina K Sukhova; Norbert Gerdes; Peter Libby
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

8.  Clonally expanded alpha-chain T-cell receptor (TCR) transcripts are present in aneurysmal lesions of patients with Abdominal Aortic Aneurysm (AAA).

Authors:  Song Lu; John V White; Raquel I Judy; Lisa L Merritt; Wan Lu Lin; Xiaoying Zhang; Charalambos Solomides; Ifeyinwa Nwaneshiudu; John Gaughan; Dimitri S Monos; Emilia L Oleszak; Chris D Platsoucas
Journal:  PLoS One       Date:  2019-07-16       Impact factor: 3.240

9.  Restenosis rates in patients with ipsilateral carotid endarterectomy and contralateral carotid artery stenting.

Authors:  Dat Tin Nguyen; Boldizsár Vokó; Balázs Bence Nyárádi; Tamás Munkácsi; Ákos Bérczi; Zoltán Vokó; Edit Dósa
Journal:  PLoS One       Date:  2022-02-11       Impact factor: 3.240

10.  Identification of Hic-5 as a novel scaffold for the MKK4/p54 JNK pathway in the development of abdominal aortic aneurysms.

Authors:  Xiao-Feng Lei; Joo-ri Kim-Kaneyama; Shigeko Arita-Okubo; Stefan Offermanns; Hiroyuki Itabe; Takuro Miyazaki; Akira Miyazaki
Journal:  J Am Heart Assoc       Date:  2014-05-08       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.